Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Bladder Cancer

Free Subscription Articles published in Cancer Retrieve available abstracts of 15 articles: HTML format

Single Articles

February 2024
1. NIERENGARTEN MB
   Major advancements in first-line treatments for advanced urothelial cancer.
   Cancer. 2024;130:333-334.
   PubMed    
   
   
   January 2024
2. PEIPERT JD, Chang J, Li S, di Pietro A, et al
   Reliability, validity, and change thresholds of the NCCN/FACT Bladder Symptom Index (NFBlSI-18) in patients with advanced urothelial cancer.
   Cancer. 2024;130:31-40.
   PubMed     Abstract available
   
   
   December 2022
3. HO MD, Modi PK
   Novel cryotherapy in non-muscle-invasive bladder cancer.
   Cancer. 2022 Dec 7. doi: 10.1002/cncr.34560.
   PubMed    
   
   
   
4. XU C, Jiang S, Zou L, Sheng L, et al
   Endoscopic balloon cryoablation plus transurethral resection for bladder cancer: A phase 2, multicenter, randomized, controlled trial.
   Cancer. 2022 Dec 7. doi: 10.1002/cncr.34563.
   PubMed     Abstract available
   
   
   October 2022
5. DOERSCH KM, Tabayoyong WB, Bandari J
   Evaluation of toxicities for intravesical drugs in phase 1 bladder cancer trials.
   Cancer. 2022 Oct 19. doi: 10.1002/cncr.34508.
   PubMed     Abstract available
   
   
   
6. JOYCE DD, Wymer KM, Sharma V, Moriarty JP, et al
   Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data.
   Cancer. 2022 Oct 17. doi: 10.1002/cncr.34502.
   PubMed     Abstract available
   
   
   August 2022
7. MARTINI A, Yu M, Raggi D, Joshi H, et al
   Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potential impact of informative censoring.
   Cancer. 2022;128:2892-2897.
   PubMed     Abstract available
   
   
   March 2022
8. KOSHKIN VS, Henderson N, James M, Natesan D, et al
   Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
   Cancer. 2022;128:1194-1205.
   PubMed     Abstract available
   
   
   September 2021
9. SMITH AB, Lee JR, Lawrence SO, Lavallee DC, et al
   Patient and public involvement in the design and conduct of a large, pragmatic observational trial to investigate recurrent, high-risk non-muscle-invasive bladder cancer.
   Cancer. 2021 Sep 8. doi: 10.1002/cncr.33897.
   PubMed     Abstract available
   
   
   July 2021
10. LAWLER C, Gu L, Howard LE, Branche B, et al
    The impact of the social construct of race on outcomes among bacille Calmette-Guerin-treated patients with high-risk non-muscle-invasive bladder cancer in an equal-access setting.
    Cancer. 2021 Jul 8. doi: 10.1002/cncr.33792.
    PubMed     Abstract available
    
    
    May 2021
11. HAEUSER L, Marchese M, Schrag D, Trinh QD, et al
    The impact of smoking on radical cystectomy complications increases in elderly patients.
    Cancer. 2021;127:1387-1394.
    PubMed     Abstract available
    
    
    March 2021
12. PRINTZ C
    Liquid biopsy test appears better at detecting bladder cancer than urine cytology.
    Cancer. 2021;127:663.
    PubMed    
    
    
    January 2021
13. LAUTZ TB, Chi YY, Li M, Wolden SL, et al
    Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group.
    Cancer. 2021;127:275-283.
    PubMed     Abstract available
    
    
    November 2020
14. GARG T, McMullen CK, Leo MC, O'Keeffe-Rosetti MC, et al
    Predicting risk of multiple levels of recurrence and progression after initial diagnosis of nonmuscle-invasive bladder cancer in a multisite, community-based cohort.
    Cancer. 2020 Nov 4. doi: 10.1002/cncr.33300.
    PubMed     Abstract available
    
    
    June 2020
15. PAL SK, Bajorin D, Dizman N, Hoffman-Censits J, et al
    Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.
    Cancer. 2020;126:2597-2606.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.